Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Glue and omental wrap may cut pancreatic surgery risks

NCT ID NCT07333755

Disease control Sponsor: Theodor Bilharz Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed Phase 4 trial tested a new surgical technique during Whipple surgery for resectable periampullary tumors. The method uses an omental patch and surgical glue to reinforce the pancreatic connection, aiming to reduce leaks, bleeding, and stomach emptying problems. Thirty patients were enrolled, comparing the new technique to standard surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
surgical procedure (pancreaticojejunostomy with omental patch and glue)
What this could lead to
If successful, this technique could lower the risk of serious complications like pancreatic leaks and bleeding after Whipple surgery.
What could go wrong
This is a small, single-center trial with only 30 participants, so results may not apply to all patients. The technique is surgical and carries standard operative risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

30 people

The number who actually took part.

Started

Nov 2023

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Resectable tumors of the periampullary region Exclusion Criteria: * Pancreatic or duodenal tumors * Irresectability criteria (such as metastases, ascites, or arterial vascular invasion)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Periampullary carcinoma resectable are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

periampullary adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Periampullary carcinoma resectable

Contacts and locations

Locations

  • Theodor Bilharz Research Institute

    Giza, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.